109
Views
15
CrossRef citations to date
0
Altmetric
Review

T-cell epitope peptide vaccines

, &
Pages 563-575 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nicole C Scharnagl & Christoph S Klade. (2007) Experimental discovery of T-cell epitopes: combining the best of classical and contemporary approaches. Expert Review of Vaccines 6:4, pages 605-615.
Read now

Articles from other publishers (14)

Sharon Nyari, Shahneaz Ali Khan, Galit Rawlinson, Courtney A. Waugh, Andrew Potter, Volker Gerdts & Peter Timms. (2018) Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein. PLOS ONE 13:6, pages e0200112.
Crossref
Dante J. Marciani. 2018. Immunology. Immunology 149 169 .
Waleed M. Hussein, Tzu-Yu Liu, Zhongfan Jia, Nigel A.J. McMillan, Michael J. Monteiro, Istvan Toth & Mariusz Skwarczynski. (2016) Multiantigenic peptide–polymer conjugates as therapeutic vaccines against cervical cancer. Bioorganic & Medicinal Chemistry 24:18, pages 4372-4380.
Crossref
Dante J. Marciani. (2016) A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies. Journal of Neurochemistry 137:5, pages 687-700.
Crossref
Toshihiro Nagato, Young-Ran Lee, Yasuaki Harabuchi & Esteban Celis. (2014) Combinatorial Immunotherapy of Polyinosinic–Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors. Clinical Cancer Research 20:5, pages 1223-1234.
Crossref
Haiyan Xiao, Yibing Peng, Yuan Hong, Lei Huang, Z. Sheng Guo, David L. Bartlett, Ning Fu, David H. Munn, Andrew Mellor & Yukai He. (2013) Local Administration of TLR Ligands Rescues the Function of Tumor-Infiltrating CD8 T Cells and Enhances the Antitumor Effect of Lentivector Immunization. The Journal of Immunology 190:11, pages 5866-5873.
Crossref
Yuan Hong, Yibing Peng, Haiyan Xiao, Michael Mi, David Munn & Yukai He. (2012) Immunoglobulin Fc Fragment Tagging Allows Strong Activation of Endogenous CD4 T Cells To Reshape the Tumor Milieu and Enhance the Antitumor Effect of Lentivector Immunization. The Journal of Immunology 188:10, pages 4819-4827.
Crossref
Haiyan Xiao, Yibing Peng, Yuan Hong, Yanjun Liu, Z. Sheng Guo, David L. Bartlett, Ning Fu & Yukai He. (2011) Lentivector Prime and Vaccinia Virus Vector Boost Generate High-Quality CD8 Memory T Cells and Prevent Autochthonous Mouse Melanoma. The Journal of Immunology 187:4, pages 1788-1796.
Crossref
Qifeng Zhou, Haiyan Xiao, Yanjun Liu, Yibing Peng, Yuan Hong, Hideo Yagita, Phillip Chandler, David H. Munn, Andrew Mellor, Ning Fu & Yukai He. (2010) Blockade of Programmed Death-1 Pathway Rescues the Effector Function of Tumor-Infiltrating T Cells and Enhances the Antitumor Efficacy of Lentivector Immunization. The Journal of Immunology 185:9, pages 5082-5092.
Crossref
Rena J. May, Tao Dao, Javier Pinilla-Ibarz, Tatyana Korontsvit, Victoriya Zakhaleva, Rong H. Zhang, Peter Maslak & David A. Scheinberg. (2007) Peptide Epitopes from the Wilms' Tumor 1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Human Malignant Mesothelioma Tumor Cells. Clinical Cancer Research 13:15, pages 4547-4555.
Crossref
Jamie P. Phelps, Nghiep Dang & Lada Rasochova. (2007) Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis. Journal of Virological Methods 141:2, pages 146-153.
Crossref
Shuyan Li, Xiaojun Yao, Huanxiang Liu, Jiazhong Li & Botao Fan. (2007) Prediction of T-cell epitopes based on least squares support vector machines and amino acid properties. Analytica Chimica Acta 584:1, pages 37-42.
Crossref
Hiroya Kobayashi, Toshihiro Nagato, Naoko Aoki, Keisuke Sato, Shoji Kimura, Masatoshi Tateno & Esteban Celis. (2005) Defining MHC class II T helper epitopes for WT1 tumor antigen. Cancer Immunology, Immunotherapy 55:7, pages 850-860.
Crossref
Manuel Schmidt, Barbara Volz & Burghardt Wittig. 2005. Modern Biopharmaceuticals. Modern Biopharmaceuticals 183 211 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.